Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Icosavax, Inc. (ICVX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
08/08/2023 8-K Investor presentation
Docs: "Slide Presentation",
"Slide Presentation"
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 144 Form 144 - Report of proposed sale of securities:
07/31/2023 144 Form 144 - Report of proposed sale of securities:
07/25/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
06/08/2023 4 MCDADE MARK (Director) has filed a Form 4 on Icosavax, Inc.
Txns: Granted 17,000 options to buy @ $9.89, valued at $168.1k
06/08/2023 4 RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Icosavax, Inc.
Txns: Granted 17,000 options to buy @ $9.89, valued at $168.1k
06/08/2023 4 Wassil Jim (Director) has filed a Form 4 on Icosavax, Inc.
Txns: Granted 17,000 options to buy @ $9.89, valued at $168.1k
06/08/2023 4 Veneman Ann M (Director) has filed a Form 4 on Icosavax, Inc.
Txns: Granted 17,000 options to buy @ $9.89, valued at $168.1k
06/08/2023 4 Shiver John W. (Director) has filed a Form 4 on Icosavax, Inc.
Txns: Granted 17,000 options to buy @ $9.89, valued at $168.1k
06/08/2023 4 FIELDS HEIDI (Director) has filed a Form 4 on Icosavax, Inc.
Txns: Granted 17,000 options to buy @ $9.89, valued at $168.1k
05/30/2023 SC 13D/A RA CAPITAL MANAGEMENT, L.P. reports a 12.5% stake in Icosavax, Inc.
05/25/2023 4 Cearley Cassia (Chief Business Officer) has filed a Form 4 on Icosavax, Inc.
Txns: Sold 10,000 shares @ $10, valued at $100k
05/23/2023 144 Form 144 - Report of proposed sale of securities:
05/23/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Opinion of Latham & Watkins LLP",
"Form of Securities Purchase Agreement"
05/23/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
Docs: "Icosavax Reports First Quarter 2023 Financial Results and Provides Corporate Update"
04/19/2023 ARS Form ARS - Annual Report to Security Holders:
04/19/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/19/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/05/2023 4 Holtzman Douglas (Chief Scientific Officer) has filed a Form 4 on Icosavax, Inc.
Txns: Sold 20,143 shares @ $6.0785, valued at $122.4k
Sold 300 shares @ $6.56, valued at $2k
Exercised 20,443 options to buy @ $1.04, valued at $21.3k
03/08/2023 4 Cearley Cassia (Chief Business Officer) has filed a Form 4 on Icosavax, Inc.
Txns: Sold 5,000 shares @ $7.7474, valued at $38.7k
02/14/2023 5 Russo Thomas Joseph (CFO) has filed a Form 5 on Icosavax, Inc.
02/14/2023 5 Kanesa-thasan Niranjan (Chief Medical Officer) has filed a Form 5 on Icosavax, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy